Publications by authors named "Nicole Renee"

Claim this Profile
P
Positive interaction between lapatinib and capecitabine in human breast cancer models: study of molecular determinants.
Mohamed Chefrour, Gérard Milano, Patricia Formento, Sarah Giacometti, Amine Denden

Fundam Clin Pharmacol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of trabectedin on hemodialysis: an application for the management of cancer patients with end-stage renal disease.
Juliette Thariat, Marie-Christine Etienne-Grimaldi, Vincent Launay-Vacher, Arturo Soto-Matos, Carlos Fernandez-Teruel

Cancer Chemother Pharmacol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tipifarnib plus tamoxifen in tamoxifen-resistant metastatic breast cancer: a negative phase II and screening of potential therapeutic markers by proteomic analysis.
Florence Dalenc, Sophie F Doisneau-Sixou, Ben C Allal, Sabrina Marsili, Valérie Lauwers-Cances

Clin Cancer Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A routine feasible HPLC analysis for the anti-angiogenic tyrosine kinase inhibitor, sunitinib, and its main metabolite, SU12662, in plasma.
Marie-Christine Etienne-Grimaldi, Nicole Renée, Hassan Izzedine, Gérard Milano

J Chromatogr B Analyt Technol Biomed Life Sci· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.
Marie-Christine Etienne-Grimaldi, Jean-Louis Formento, Mireille Francoual, Eric François, Patricia Formento

Clin Cancer Res· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimized blood sampling with cytidine deaminase inhibitor for improved analysis of capecitabine metabolites.
Thierry Besnard, Nicole Renée, Marie-Christine Etienne-Grimaldi, Eric François, Gérard Milano

J Chromatogr B Analyt Technol Biomed Life Sci· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical pharmacokinetic analysis of tegafur-uracil (UFT) plus leucovorin given in a new twice-daily oral administration schedule.
Marie-Christine Etienne-Grimaldi, Eric François, Jean-Michel Cardot, Nicole Renée, Jean-Yves Douillard

Clin Pharmacokinet· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydropyrimidine dehydrogenase activity and the IVS14+1G>A mutation in patients developing 5FU-related toxicity.
Nicolas Magné, Marie-Christine Etienne-Grimaldi, Laurent Cals, Nicole Renée, Jean-Louis Formento

Br J Clin Pharmacol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics of capecitabine in advanced breast cancer patients.
Rémy Largillier, Marie-Christine Etienne-Grimaldi, Jean-Louis Formento, Joseph Ciccolini, Jean-François Nebbia

Clin Cancer Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taxotere-5'-deoxy-5-fluorouridine combination on hormone-refractory human prostate cancer cells.
Jean-Louis Fischel, Jean-Marc Ferrero, Patricia Formento, Joseph Ciccolini, Nicole Renée

Anticancer Drugs· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single ascending dose tolerability, pharmacokinetic-pharmacodynamic study of dihydropyrimidine dehydrogenase inhibitor Ro 09-4889.
S Eralp Bellibas, Indra Patel, Emmanuel Chamorey, Bettyna Brivet, Ernest D Bush

Clin Cancer Res· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter phase II feasibility trial of high-dose tamoxifen in patients with refractory or relapsed multiple myeloma.
Didier Decaudin, Marie-Christine Etienne, Patricia De Cremoux, Zofia Maciorowski, Jean-Marie Vantelon

J Natl Cancer Inst· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: rational basis for a new combination therapy with capecitabine.
Nicolas Magné, Jean-Louis Fischel, Alain Dubreuil, Patricia Formento, Joseph Ciccolini

Clin Cancer Res· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses.
Marie-Christine Etienne, Maurice Chazal, Pierre Laurent-Puig, Nicolas Magné, Christophe Rosty

J Clin Oncol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis